Trademark Overview
On Friday, June 20, 2025, a trademark application was filed for SYNT with the United States Patent and Trademark Office. The USPTO has given the SYNT trademark a serial number of 99245099. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 20, 2025. This trademark is owned by Syntis Bio, Inc.. The SYNT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of metabolic diseases and disorders.; Pharmaceutical preparations for the treatment of weight gain and obesity; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, and degenerative conditions associated with aging.; Pharmaceutical preparations for the treatment and prevention of chronic diseases, conditions, and functional disorders; Biological preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents